The aim of this meta-analysis was to collect data from randomized trials in burn patients and to analyze them with a meta-analytic approach to give a clear message of potential advantages of nanocrystalline silver (NC) versus older silver formulations (SS).
S ilver is an ion commonly used in dermatology and plastic surgery for the prevention and treatment of wound infections due to a strong antimicrobial activity. [1] [2] [3] [4] It is effective on aerobic, anaerobic, Gram negative, Gram-positive bacteria, and fungi by precipitating the proteins through a combination with chloride in tissues, and by blocking the microbial respiratory chain system. [5] [6] Its effectiveness was proved in different clinical settings such as pressure sores, diabetic, and venous ulcerations, [7] [8] [9] [10] [11] and on burn patients its use significantly decreased the incidence of sepsis when combined with systemic antibiotics. 12 Older silver formulations usually contained silver ions in the form of silver nitrate (AgNO 3 ) and silver sulfadiazine (Silvazine-Smith and Nephew, Hull, UK). These dressings, used for many decades, were effective in the prevention of infection but rapidly inactivated by the wound environment, thus requiring frequent replenishments to achieve an effective local ion concentration. Consequently, frequent changes often led to delayed wound healings, increased pain and costs. 13 Newer silver formulations are manufactured in the form of high-density polyethylene mesh with nanocrystalline silver (Acticoat, Smith and Nephew, Hull, UK) or embedded in hydrofibers (Aquacel AG, ConvaTec Bristol-Myers Squibb Company, Skillman, NJ). Such formulations were equally effective to prevent infections than older formulations, but allowed a higher interval of time between dressing changes and, in some cases, the specific properties of some components rendered the medication highly effective, ie, hydrofibers on exudative wounds. This provided caregivers with the possibility to choose the most appropriate dressing according to the local wound situation. 14 Nanocrystalline (NC) silver is one of the recently introduced silver dressings. It is composed of a urethane film onto which nanocrystalline elemental silver is deposited. This particular formulation provides a sustained release of elemental silver with the possibility to delay wound changes up to once weekly. 13 Furthermore, recent studies have also suggested that NC has a greater ability to prevent burn infections compared with older formulations. [15] [16] [17] [18] [19] In the present review, we collected data from randomized trials on burn patients and analyzed them with a meta-analytic approach to give a clear message on NC and the potential advantages it carries over older silver formulations.
MATERIALS AND METHODS

Study Selection and Data Extraction
English-language published randomized controlled trials of NC, classic silver sulfadiazine, or silver nitrate (SS) conducted on burn patients were searched and selected in the MEDLINE, EMBASE, and Cochrane Library databases using key words silver, dressing, Acticoat, nanocrystalline, silver sulfadiazine, silver nitrate, burns, deep partial thickness. We defined a randomized trial as one in which patients were assigned prospectively to NC or SS by a random allocation. Potentially relevant studies were identified by the title and the abstract and full papers were obtained and assessed in details. The methodological quality of studies was assessed independently by 2 reviewers. A specifically designed data form was used to collect all relevant data, including details of the experimental design, patients' demographics, technical aspects, and outcome measures. Data collection was carried out independently by 2 researchers and then compared.
Primary outcome of our review was to find eventual differences in the ability of silver dressings to prevent burn infections. Secondary outcomes were to compare the pain during medications, the length of hospitalization (LOS) and costs.
Statistical Analysis
Data analysis was performed using the Statistical Package for the Social Sciences Windows version 13.0 (SPSS, Chicago, IL) and the meta-analysis with interactive explanations (MIX-version 1.6) program. Descriptive statistics for qualitative variables was performed with occurrences and described with relative frequencies, those for continuous variables with the mean and standard deviation if parametric or median and range if non parametric. Clinical outcomes and complications of patients in the NC and SS group were evaluated with common tests used in meta-analyses: 2 test or Fisher exact test for categorical variables, Hedges' G (HG) standardized measure of effect for continuous and ordinal variables. The weighted odds ratio (OR) for the occurrence of infections between NC and SS was also calculated. The model used for the metaanalysis was the fixed-effect and the weighting method was the Mantel Haenszel. Results were considered significant if the probability of chance of occurrence was less than 5% (P Ͻ 0.05).
RESULTS
Five randomized controlled trials that met the including criteria and satisfied the primary or secondary outcomes were identified (Table 1) . [15] [16] [17] [18] [19] Twelve studies were excluded 20 -31 : 5 because they were conducted in vitro or on animal models, 20 -24 5 because they did not use silver nanocrystalline dressings as experimental treatment, 25-29 1 because it did not use either silver sulfadiazine or silver nitrate as control treatment, 30 and 1 study because it did not analyze either the primary or the secondary outcomes of the meta-analysis. 31 The 5 selected studies included a total of 285 patients, 105 in the NC group and 180 in the SS group. In 4 studies, NC was compared with silver sulfadiazine, 16 -19 and in 1 study with silver nitrate. 15 Four studies involved adult burned patients [15] [16] [17] [18] and 1 study involved only children. 19 The range of mean age values was 3 to 41 years.
The incidence of infections in the NC groups dressing varied from 0% 17, 19 to 12%. 18 The incidence of infections with SS dressing varied from 0% 17 to 55%. 16 According to the primary outcome of this meta-analysis, patients in the NC group had a significantly lower incidence of infections than that of the SS group (9.5%, 10/105 vs. 27.8%, 50/180; 2 test, P Ͻ 0.001; Fig. 1 ) [15] [16] [17] [18] [19] with an OR of 0.14 (95% CI: 0.06 -0.35). The SS group had a 2.9-fold increase in the risk to develop infections compared with the NC group.
Four studies analyzed adult patients, 75 in the NC group and 107 in the SS group. [15] [16] [17] [18] The incidence of burn infections in the SS group (37/107 ϭ 34.6%) was 4.3 times higher than that of the NC group (6/75 ϭ 8.0%; 2 test: P Ͻ 0.05). [15] [16] [17] [18] On the contrary, no difference was observed between the NC group and the SS group in the study involving the pediatric population (NC ϭ 0% vs. SS ϭ 2.7%; Fisher exact test: P ϭ NS). 19 Furthermore, 4 studies compared NC (n ϭ 88 patients) with silver sulfadiazine (n ϭ 163 patients). 16 -19 The incidence of burn infections in the group of patients treated with silver sulfadiazine (34/163 ϭ 20.9%) was 3.7 times higher than that of the NC group (5/88 ϭ 5.7%; 2 test: P Ͻ 0.05). 16 -19 In the study that used silver nitrate as control, the incidence of infections in the SS group (5/17 ϭ 29.4%) was 5-times greater than in the NC (1/17 ϭ 5.9%), but this difference was not significant (Fisher exact test: P ϭ NS). 15 Pain scores in both groups were obtained during the initial application on morning dressing changes in 3 studies for a total of 112 patients, 56 in the NC group and 56 in the SS group. 15, 17, 18 Two studies used the visual analog pain scale (1 to 10; 0 being no pain, 5 being moderate pain, and 10 being severe pain). 17, 18 One study used a different visual analogic pain scale (1 to 5; 1 being not painful, 5 being very painful). 15 Two studies found a significant difference between the NC group and the SS group: patients undergoing NC experienced significantly less pain than those undergoing SS. 17, 18 In one study, patients found dressing removal significantly painful with NC versus SS, although it was comparable during the applications and at 2 hours after completion of the dressing change. 15 A correction of the scale used by Tredget et al 15 was necessary to compare it with the 0 to 10 VAS scales. We used a correction factor of 2.2 for all pain values reported by Tredget (VAS score ϭ 2.2 ϫ Tredget pain values). The overall analysis showed that a significant reduction of the pain was present in the NC group compared with the SS group (HG: Ϫ1.44 ͓95% CI: Ϫ1.86/Ϫ1.01͔; P Ͻ 0.0001; Fig. 2 ). LOS was reported in 2 studies involving 55 patients in the NC group and 98 patients in the SS group. 18, 19 While the study of Muangman et al found no significant differences between groups, 18 the study of Peters and Verchere showed a significant shorter LOS for the patients treated with NC. 19 Finally, only 1 study analyzed costs. 16 The average cost per patient during hospitalization (excluding individual antibiotic, surgery and staffing costs) was US $27,339 in the SS group and US $19,726 in the NC group. The average dressing cost was US $1533 per patient for the SS group and US $946 per patient for the NC group. 16 
DISCUSSION
Infections remain the leading cause of death among burn patients. 32, 33 Bacteria are the most frequent etiologic agents, although in recent years secondary fungal opportunistic infections have been diagnosed in patients with large burns (Ͼ40% of total burn surface area) and receiving broad-spectrum antibiotics. 34 -36 Two factors mainly contribute to the high incidence of infections in the burned population: the disruption of the skin's barrier integrity and the postburn immune suppression. [37] [38] [39] [40] In fact, the thermal damage destroys the epidermis and produces areas of coagulative necrosis surrounded by pronounced inflammation and hyperemia. Additionally, dermal apoptotic cells further enlarge the damaged areas, 41, 42 while phagocytic and immune cells are impaired in their activities. 38 -40 The development and clinical use of effective topical antimicrobial agents significantly decreased the incidence of infections in burn patients and this, along with the introduction of early escarectomies, greatly improved the survival of burn patients in the last decade. 33 Silver in its numerous forms has been used for over 200 years in the treatment of burn injury 43 and is actually present in 4 different formulations: high-density polyethylene mesh with nanocrystalline dressings (Acticoat, Smith and Nephew), hydrofibers with silver (Aquacel AG, ConvaTec Bristol-Myers Squibb Company), silver sulfadiazine (Silvazine, Smith and Nephew), and silver nitrate. All of them gave positive results for the prevention and treatment of infections and the different formulations may be used according to the patient's clinical necessities. 14 However, tissue irritation (silver nitrate) and inactivation of much of the silver by the wound fluid with formation of a pseudo-eschar (silver sulfadiazine) are some limitations that were described for older silver products. 13 Three experimental investigations initially compared the effect of NC with other silver dressings and demonstrated that the former performed better and faster in killing bacteria. 44 -46 Clinically, the findings of our meta-analysis indicate that the incidence of burn wound infections is significantly decreased with use of NC versus SS. Furthermore, as a consequence of the use of NC dressings, some authors reported less frequent occurrence of secondary bacteraemia from infected burn wounds and a decrease in the use of antibiotics compared with older silver formulations. [15] [16] This was related by Huang et al to the decreased healing time that they observed in NC patients compared with SS patients. 31 Different authors found that the overall magnitude of pain in wounds treated with NC was significantly lower than wounds treated with SS. 15, 17, 18 This might be due to its long lasting properties that reduce dressing change frequency compared with silver sulfadiazine. In fact, staff working with SS and NC dressings made subjective observations that patient comfort and anxiety for medication improved with NC as they were required to change them not daily but only 1 to 2 times weekly. This also led to verbalization of improved feeling of well being, greater patient's mobility and increased participation in physical therapy as reported also in previous studies. 14 -16,47 LOS was reduced in the NC group in the study on pediatric patients. 19 This offered the potential advantages of less nosocomial infection and decreased costs. Because children with medium-sized burns did not experience much pain between dressing changes and NC required changes only twice a week, the authors were able to discharge them from hospital much earlier. In this case, caregivers kept NC dressing moist and in place at home and children returned to the burn unit twice weekly for dressing changes. At that time, they received analgesic medications and anesthesia as required and remained in the hospital for a short period of time to recover from anesthesia. 19 Considering costs, previous studies demonstrated that significant savings in materials and labor could be achieved by reducing the number of dressing changes. 47 Furthermore, as outlined before, Peters and Verchere proved it by reducing the number of days spent into hospitals by their patients. 19 The study of Fong specifically addressed this issue, and cost estimates indicated that patients treated with NC spent less days in hospital and were discharged earlier than the SS group. The average cost per patient for the SS group was US $27,339 and for the NC group US $19,726, a cost saving of US $7613 per patient. 16 Based on these findings, older silver formulations (ie, silver sulfadiazine) did not prove advantageous in any of the parameter analyzed (infection prevention, pain related to wound changing, costs) and it is hard, with these premises, to make any eventual hypothesis for a place in an evidence-based algorithm of treatment. However, we still believe that the creamy formulation of silver sulfadiazine could be useful to prevent joint retraction and arthritis when early mobilizations of joints are required, ie, when burns involve hands. In these cases, the peculiar creamy formulation allows an easier application of the silver sulfadiazine in gloves dressings, with a greater possibility to mobilize joints than with common gauzes. 14 A possible bias of this meta-analysis derives from the absence of harmonization of certain variables between studies analyzed, ie, the method of application of nanocrystalline silver, the decision on the presence or absence of an infectious complication and the difference in the anatomic regions involved. Similarly, too often important variables like the etiology, severity, extent and location of the burn injury, age, and gender of patients were omitted in studies analyzed influencing the evaluation of homogeneity among the selected studies. In fact, the treatment modality and selection of dressings are highly influenced by these factors and may not be extrapolated to all burn injuries. However, still with these limitations 
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A Meta-analysis of Nanocrystalline Silver we believe that the information derived from our overall analysis could be the first important evidence-based information in a field (burn dressings) that is too often left to the clinical personal experience or beliefs. Once these issues will be solved, the next step will be to draw an evidence-based approach also for nonsilver-based antiseptic dressings (ie, cadexomer iodine, povidone iodine, peroxide-based preparations, ethacridine lactate, mupirocin), as already done on patients affected by venous leg ulcers. 48 Future studies could compare these products with silver dressings, especially nanocrystalline silver, to determine which one is superior with respect to infection control, pain reduction, promotion of wound healing, and toxicity.
CONCLUSIONS
NC dressings proved to be superior for the prevention of infections in burn patients, significantly reducing their incidence compared with older silver formulation. NC could also reduce the costs and the pain associated with the change of dressings, as these were lower for NC group when data were reported. If confirmed by future randomized studies, such data could form the basis for a more evidence-based use of silver dressings in burns infection control.
